









Markets
/
Stocks
/
nasdaq-apge
/

Apogee Therapeutics Inc

APGE

77.820USD

-0.600-0.77%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

3.71BMarket Cap

LossP/E TTM



Apogee Therapeutics Inc

77.820

-0.600-0.77%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Apogee Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

7.42%-62.69M

-27.59%-54.26M

-111.70%-62.03M

-53.23%-48.48M

-127.58%-67.71M

-113.90%-42.52M

-101.10%-29.30M

-199.67%-31.64M

---29.75M

---19.88M

---14.57M

---10.56M

--0.00

Net income from continuing operations

-3.23%-69.39M

-32.65%-65.02M

-95.46%-66.10M

-72.43%-55.34M

-111.81%-67.22M

-135.21%-49.02M

-79.06%-33.82M

-156.24%-32.09M

---31.73M

---20.84M

---18.89M

-190.94%-12.53M

---4.30M

Operating gains losses

434.21%406.00K

745.83%406.00K

1008.33%399.00K

613.79%207.00K

--76.00K

--48.00K

--36.00K

--29.00K

----

Other non-cash items

64.81%-783.00K

78.19%-680.00K

69.60%-839.00K

37.73%-1.52M

19.15%-2.23M

-1243.97%-3.12M

---2.76M

---2.44M

---2.75M

---232.00K

----

-100.00%0.00

--1.69M

Change in working capital

18.49%-4.86M

-122.47%-837.00K

-543.39%-6.84M

-124.60%-2.95M

-336.16%-5.96M

1290.10%3.73M

-51.84%1.54M

-289.19%-1.31M

--2.52M

---313.00K

--3.20M

-73.48%694.00K

--2.62M

-Change in prepaid expenses

375.50%1.64M

25.03%-2.11M

-109.15%-2.54M

161.22%895.00K

-196.60%-596.00K

-95.34%-2.81M

36.82%-1.21M

-3222.73%-1.46M

--617.00K

---1.44M

---1.92M

---44.00K

--0.00

-Change in other current assets

356.25%73.00K

-293.48%-181.00K

-2165.67%-1.52M

---6.84M

114.95%16.00K

---46.00K

---67.00K

----

---107.00K

----

Cash from non-recurring investing activities

Cash from operating activities

7.42%-62.69M

-27.59%-54.26M

-111.70%-62.03M

-53.23%-48.48M

-127.58%-67.71M

-113.90%-42.52M

-101.10%-29.30M

-199.67%-31.64M

---29.75M

---19.88M

---14.57M

---10.56M

--0.00

Investing cash flow

Net cash from continuing investing activities

6300.00%62.00K

-100.00%0.00

1405.88%768.00K

1129.91%4.32M

-100.60%-1.00K

--751.00K

--51.00K

--351.00K

--167.00K

----

Capital expenditures

--62.00K

-100.00%0.00

1405.88%768.00K

1129.91%4.32M

----

--751.00K

--51.00K

--351.00K

--167.00K

----

Net cash flow from disposal of fixed assets

6300.00%62.00K

-100.00%0.00

1405.88%768.00K

1129.91%4.32M

-100.60%-1.00K

--751.00K

--51.00K

--351.00K

--167.00K

----

Net cash flow from investment products

-722.36%-288.56M

112.32%17.95M

153.07%78.89M

133.66%17.30M

217.31%46.37M

37.82%-145.63M

---148.66M

---51.39M

---39.52M

---234.22M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-722.48%-288.63M

112.26%17.95M

152.54%78.13M

125.09%12.98M

216.82%46.37M

37.50%-146.38M

---148.71M

---51.74M

---39.69M

---234.22M

----

Financing cash flow

Cash flow from continuous financing activities

745.32%374.95M

5053.52%19.74M

886.67%1.18M

-99.86%622.00K

20924.41%44.36M

-99.88%383.00K

91.15%-150.00K

--450.52M

---213.00K

--317.30M

---1.69M

-100.00%0.00

--5.00M

Net cash flow from common stock issuance/repurchase

750.61%370.25M

--19.38M

100.00%0.00

-100.00%0.00

--43.53M

-100.00%0.00

---541.00K

--450.50M

----

--315.60M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--5.00M

Proceeds from stock option exercised by employees

467.39%4.70M

-7.05%356.00K

201.79%1.18M

2491.67%622.00K

--828.00K

--383.00K

--391.00K

--24.00K

----

Net cash flow from other financing activities

--46.20M

--19.38M

----

--1.69M

---1.69M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

745.32%374.95M

5053.52%19.74M

886.67%1.18M

-99.86%622.00K

20924.41%44.36M

-99.88%383.00K

91.15%-150.00K

--450.52M

---213.00K

--317.30M

---1.69M

-100.00%0.00

--5.00M

Net cash flow

Beginning cash balance

-9.37%107.91M

-59.53%124.49M

-77.93%107.21M

19.79%142.08M

-36.75%119.07M

145.94%307.59M

243.69%485.75M

-21.91%118.61M

--188.27M

--125.07M

--141.33M

--151.89M

--0.00

Current period cash flow changes

2.72%23.64M

91.21%-16.57M

109.70%17.28M

-109.50%-34.87M

133.03%23.01M

-398.29%-188.52M

-995.41%-178.16M

3577.70%367.14M

---69.66M

--63.20M

---16.26M

-311.14%-10.56M

--5.00M

Ending cash balance

-7.41%131.55M

-9.37%107.91M

-59.53%124.49M

-77.93%107.21M

19.79%142.08M

-36.75%119.07M

145.94%307.59M

243.69%485.75M

--118.61M

--188.27M

--125.07M

2726.66%141.33M

--5.00M

Free cash flow

---62.75M

-25.37%-54.26M

-113.95%-62.80M

-65.05%-52.79M

----

-117.68%-43.27M

---29.35M

---31.99M

---29.92M

---19.88M

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

